Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÀÎü À§¾Ï ¼¼Æ÷ÁÖ¿¡ retroviral vector¸¦ ÀÌ¿ëÇÑ p53 Á¾¾ç ¾ïÁ¦ À¯ÀüÀÚÀÇ ÇüÁúµµÀÔ¿¡ °üÇÑ ¿¬±¸ A Study of Retrovirus-mediated p53 Gene Transduction Into Human Gastric Cancer Cell Lines

´ëÇѾÏÇÐȸÁö 1997³â 29±Ç 5È£ p.754 ~ 764
¼Ò¼Ó »ó¼¼Á¤º¸
±èÁÖÇ×/Joo-Hang Kim

Abstract

°á·Ð
Retrovirus¸¦ ÀÌ¿ëÇÑ p53 À¯ÀüÀÚÀÇ ÇüÁúµµÀÔ¿¡ ÀÇÇÑ À§¾Ï ¼¼Æ÷ÁÖÀÇ ¼ºÀå ¾ïÁ¦ È¿°ú´Â p53
À¯ÀüÀÚÀÇ µ¹¿¬º¯À̸¦ ÇÔÀ¯ÇÏ°í ÀÖ´Â N-87 À§¾Ï ¼¼Æ÷ÁÖ¿¡¼­ ¶Ñ·ÇÇÏ¿´À¸³ª Á¤»óÇüÀÇ p53 À¯
ÀüÀÚ¸¦ °¡Áø YCC-S-2 ¼¼Æ÷ÁÖ¿¡¼­´Â ¼ºÀå¾ïÁ¦È¿°ú°¡ ¾ø¾ú´Ù. ±×¸®°í ½ÇÇè µ¿¹°¿¡¼­ N-87
À§¾Ï ¼¼Æ÷ÁÖ¿¡ ÀÇÇØ À¯¹ßµÈ Á¾±«´Â retrovirus¸¦ ÀÌ¿ëÇÑ P53 À¯ÀüÀÚÀÇ ÇüÁúµµÀÔÀ¸·Î Á¾±«ÀÇ
¼ºÀå ¾ïÁ¦¸¦ °üÂûÇÒ ¼ö ÀÖ¾úÀ¸³ª Á¤»óÇüÀÇ p53 À¯ÀüÀÚ¸¦ °¡Áø YCC-S-2 ¼¼Æ÷ÁÖ¿¡ ÀÇÇØ Çü
¼ºµÈ Á¾±«ÀÇ ¼ºÀå¿¡´Â ¿µÇâÀ» ¹ÌÄ¡Áö ¸øÇÏ¿´´Ù.
º» ¿¬±¸¿¡¼­ p53 À¯ÀüÀÚÀÇ ÇüÁúµµÀÔ¿¡ ÀÇÇÑ À§¾Ï ¼¼Æ÷ÁÖÀÇ ¼ºÀå ¾ïÁ¦ È¿°ú°¡ ¿ÏÀüÇÏÁö
¾Ê¾Ò´ø °ÍÀº retrovirus¸¦ ÀÌ¿ëÇÑ À¯ÀüÀÚÀÇ ÇüÁúµµÀԽà ³·Àº ÇüÁúµµÀÔ È¿À²ÀÌ ÁÖµÈ ¿øÀÎÀÎ
°ÍÀ¸·Î »ý°¢µÇ¸ç, ÇâÈÄ retrovirusÀÇ °¨¿° È¿À²°³¼±¿¡ °üÇÑ ¿¬±¸°¡ ÇÊ¿äÇϸ®¶ó°í º»´Ù.
#ÃÊ·Ï#
Purpose : The development of new therapeutic modalities such as gene therapy, which
still requires further investigation, is clearly important to improve the prognosis of
gastric cancer. This study was conducted to evaluate the effect on the growth and the
tumorigenicity of retrovirus-mediated p53 gene transduction into gastric cancer cells.
Materials and methods : Human gastric cancer cell lines were cultured and their
DNAs were analyzed to evaluate the p53 status with PCR-SSCP(polymerase chain
reaction-single strand conformation polymorphism) and DNA sequencing. Retroviral
supernatants were obtained from each producer cell line, PA317/LNCX and
PA317/LNC/p53, after construction of retroviral vector LNC/P53 containing human p53
cDNA and producer cell line PA 317/LNC/p53. To investigate the effect of
retrovirus-mediated p53 gene transduction in human gastric cancer cell lines, the if vitro
growth rates and in vivo tumorigenicities of the N-87 cell line having mutant p53 and
the YCC-S-2 cell line having wild-type p53 were compared before and after infection
with LNC/p53 retrovirus.
Results : 1%e following results were obtained: 1) The growth inhibition of N-87 cells
after p53 transduction was significant when compared to that of the parent N-87 cells.
The growth of the p53 transduced YCC-S-2 cells and the parent YCC-S-2 cells was
not different. 2) In nude mice, the growth of tumors formed by N-87 cells was
modestly inhibited after retrovirus-mediated wild-type p53 gene transduction. However,
the growth of tumors formed by YCC-S-2 cells was not inhibited by
retrovirus-mediated p53 gene transduction. 3) The expression rate of p53 protein after
p53-containing retroviral infection in the KATO-¥² cell lines, which have no p53 gene,
was dose-dependent on the m.o.i. of retrovirus, although it was not more than 15% with
the m.o.i. of 100 upon immunohistochemical analysis.
Conclusion : The growth inhibition by retrovirus-mediated p53 transduction in human
gastric cancer cells was significant in a gastric cancer cell line having mutant p53 in
vitro, and the growth of tumor masses formed by a gastric cancer cell line having
mutant p53 was modestly inhibited after p53 transduction using retroviral vector in nude
mice, although it was not statistically significant. Only modest inhibition of tumor
growth using retrovirus-mediated p53 gene transduction in vivo is most likely to be due
to low transduction efficiency.

Å°¿öµå

Gastric cancer cell; Gene therapy; Retroviral vector; p53 gene;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS